Team Profile

We are riding in support of cancer immunotherapy research at the Georgetown-
Lombardi Comprehensive Cancer Center. Over the past decade cancer immunotherapy
research has transformed the treatment of over 20 different types of cancer. Research
at Georgetown-Lombardi has been particularly instrumental in improving the outcome of
patients with either advanced melanoma or kidney cancer from diseases that were
nearly universally fatal to ones where close to half of patients can now expect to live a
normal lifespan free of cancer and cancer treatment. Despite these remarkable
advances, there is still much to be done and we are diligently working on the next set of
advances. If you are a cancer survivor due to immunotherapy and/or have a family
member or friend whose life has been impacted by cancer immunotherapy, please join
and/or support Team Immunotherapy for Bellringer 2024.